Pulmonary Disease, Chronic Obstructive
Conditions
Brief summary
A pharmaco-epidemiological, observational study that aimed at assessing in a prospective manner the evolution of Quality of Life (QOL) in chronic obstructive pulmonary disease (COPD) patients treated with inhaled bronchodilators
Interventions
Sponsors
Boehringer Ingelheim
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Diagnosis of COPD confirmed by Pulmonary Function Test (PFTs) * Recent treatment with a free or fixed association of inhaled bronchodilators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of health-related quality of life (Short-Form Health Survey) | 4 months |
Outcome results
None listed